Imagine trying to guide a tiny tool through a blood vessel, but instead of using X-rays that expose you to radiation, you use an MRI. This technology adds a special 'magnetic paint' to the tools so they glow brightly on the scan. Then, a smart computer program acts like a GPS, tracking the tool's movement in real-time so the doctor knows exactly where it is.
Interventional radiology currently relies on radiation and contrast agents because standard tools are not visible under MRI. This creates health risks for patients and limits the use of MRI for real-time surgical guidance.
A two-part system: a proprietary nano-coating (MagnaFy) to make medical tools visible in MRI, and a deep-learning software for real-time tracking of those tools.
If you are a device maker dealing with low visibility of tools during MRI procedures — this project developed a nano-coating platform that makes any commercial device MR-visible. This allows your products to be used in radiation-free interventions. It targets a market of over 700 million patients worldwide.
If you are a scanner manufacturer dealing with the lack of real-time guidance tools for surgeons — this project developed deep learning software that tracks coated devices. By integrating this into the scanner platform, you provide a turn-key solution for interventional radiology. A letter of intent with Siemens Healthineers already exists for this integration.
If you are a clinic dealing with the risks of radiation and contrast agents during stenting or angioplasty — this project developed a system for MRI-guided procedures. This enables safer treatments for patients without the need for ionizing radiation. It specifically benefits cardiovascular and pediatric cardiology procedures.
Based on available project data, the platform is intended to be commercialized as a B2B service to interventional device makers, though specific pricing is not disclosed.
Yes, the nano-coating can be applied to any commercial interventional device, and the software is being integrated into market-leading MRI scanner systems like those from Siemens.
The project utilizes proprietary MagnaFy technology for the nano-coating platform. Based on available project data, the business model is a B2B service for device makers.
The company is preparing a validation set using clinical data from their EmeryGlide product, which is required before FDA submission of the software.
A letter of intent with Siemens Healthineers enables integration into the MAGNETOM Application Platform, providing broad market access.
The project is led by a single German SME, Nano4Imaging GmbH, representing a 100% industry ratio. While the consortium is small (1 partner), the business strength is derived from external strategic collaborations with major industry players including Siemens Healthineers, Philips, Terumo, B.Braun, COOK, and Numed.
Contact Nano4Imaging GmbH in Germany regarding MagnaFy coating and TRACKR software
Contact us to explore B2B licensing for MR-visible medical coatings.
